Zota Health Care LImited Asset Resilience Ratio
Zota Health Care LImited asset resilience ratio. Zota Health Care LImited (ZOTA) has an Asset Resilience Ratio of 0.68% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Zota Health Care LImited to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Zota Health Care LImited (2016–2025)
Asset resilience ratio of Zota Health Care LImited from 2016 to 2025. This chart shows how Zota Health Care LImited's Asset Resilience Ratio has changed over time. Read ZOTA total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Zota Health Care LImited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ZOTA asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs14.87 Million | 0.34% |
| Short-term Investments | Rs14.87 Million | 0.34% |
| Total Liquid Assets | Rs29.74 Million | 0.68% |
Asset Resilience Insights
- Limited Liquidity: Zota Health Care LImited maintains only 0.68% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Zota Health Care LImited Industry Peers by Asset Resilience Ratio
Compare Zota Health Care LImited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL |
Biotechnology | 62.31% |
|
Verona Pharma plc
F:I9SA |
Biotechnology | 0.00% |
|
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA |
Biotechnology | 33.37% |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
Biotechnology | 2.03% |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161 |
Biotechnology | 8.08% |
|
Bavarian Nordic
CO:BAVA |
Biotechnology | 10.83% |
|
Hebei Changshan Biochem Pharma
SHE:300255 |
Biotechnology | -0.03% |
|
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287 |
Biotechnology | 37.31% |
Zota Health Care LImited Asset Resilience Ratio by Year (2016–2025)
Zota Health Care LImited asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Zota Health Care LImited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 0.68% | Rs29.74 Million ≈ $321.63K |
Rs4.39 Billion ≈ $47.49 Million |
+0.39pp |
| 2024-03-31 | 0.29% | Rs6.56 Million ≈ $70.94K |
Rs2.28 Billion ≈ $24.69 Million |
-1.01pp |
| 2023-03-31 | 1.29% | Rs20.46 Million ≈ $221.29K |
Rs1.58 Billion ≈ $17.10 Million |
-1.96pp |
| 2022-03-31 | 3.25% | Rs45.22 Million ≈ $489.02K |
Rs1.39 Billion ≈ $15.04 Million |
+0.16pp |
| 2021-03-31 | 3.09% | Rs26.39 Million ≈ $285.35K |
Rs854.69 Million ≈ $9.24 Million |
+1.26pp |
| 2020-03-31 | 1.83% | Rs16.21 Million ≈ $175.29K |
Rs884.79 Million ≈ $9.57 Million |
+1.83pp |
| 2019-03-31 | 0.00% | Rs120.00 ≈ $1.30 |
Rs896.07 Million ≈ $9.69 Million |
+0.22pp |
| 2018-03-31 | -0.22% | Rs-2.00 Million ≈ $-21.63K |
Rs917.94 Million ≈ $9.93 Million |
+0.03pp |
| 2016-03-31 | -0.24% | Rs-1.08 Million ≈ $-11.63K |
Rs440.52 Million ≈ $4.76 Million |
-- |
About Zota Health Care LImited
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders. The company operates its retail stores u… Read more